Allt inom Report
Nanexa publishes interim report for January – June 2022
The pilot plant inaugurated and GMP certified, patent approved in Europe and product projects approaching clinical phase
Nanexa publishes interim report for January – March 2022
Positive development in the product projects and in the patent portfolio